What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Ralf Dechend mostly deals with Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Receptor.
Ralf Dechend studied Internal medicine and Placenta that intersect with Plasma renin activity and Vitamin C.
His research on Endocrinology often connects related topics like Preeclampsia.
The study incorporates disciplines such as Tumor necrosis factor alpha, Inflammation, Endothelin receptor, Valsartan and Kidney in addition to Angiotensin II.
His Renin–angiotensin system research includes elements of Mineralocorticoid, Aldosterone, Muscle hypertrophy and Kinase.
Ralf Dechend has researched Receptor in several fields, including Epitope and Cell biology.
His most cited work include:
- Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. (626 citations)
- Salt-responsive gut commensal modulates TH17 axis and disease (410 citations)
- Salt-responsive gut commensal modulates TH17 axis and disease (410 citations)
What are the main themes of his work throughout his whole career to date?
Ralf Dechend mainly focuses on Internal medicine, Endocrinology, Preeclampsia, Angiotensin II and Blood pressure.
In his work, Diastole is strongly intertwined with Cardiology, which is a subfield of Internal medicine.
He combines subjects such as Inflammation and Ischemia with his study of Endocrinology.
He works mostly in the field of Preeclampsia, limiting it down to concerns involving Autoantibody and, occasionally, Type i receptor.
Ralf Dechend interconnects Fibrosis, Reactive oxygen species, Cerivastatin and Immunology in the investigation of issues within Angiotensin II.
His Blood pressure research incorporates elements of Vitamin D and neurology, Cohort and Intensive care medicine.
He most often published in these fields:
- Internal medicine (67.45%)
- Endocrinology (52.22%)
- Preeclampsia (39.34%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (67.45%)
- Preeclampsia (39.34%)
- Pregnancy (19.67%)
In recent papers he was focusing on the following fields of study:
Ralf Dechend mainly investigates Internal medicine, Preeclampsia, Pregnancy, Endocrinology and Blood pressure.
In most of his Internal medicine studies, his work intersects topics such as Cardiology.
The Preeclampsia study combines topics in areas such as Autoantibody, Albuminuria, Fetus and Obstetrics.
His study in Endocrinology is interdisciplinary in nature, drawing from both Inflammation, Trophoblast and Ischemia.
The various areas that Ralf Dechend examines in his Blood pressure study include Gut flora, Case-control study, Fatty acid, Vitamin D and neurology and Cohort.
His Angiotensin II study frequently draws connections to adjacent fields such as Kidney.
Between 2016 and 2021, his most popular works were:
- Salt-responsive gut commensal modulates TH17 axis and disease (410 citations)
- Salt-responsive gut commensal modulates TH17 axis and disease (410 citations)
- Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage (111 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His main research concerns Internal medicine, Preeclampsia, Endocrinology, Pregnancy and Blood pressure.
Internal medicine is closely attributed to Cardiology in his research.
His Preeclampsia research is multidisciplinary, incorporating elements of Receptor, Andrology, Spiral artery and Intrauterine growth restriction.
He studies Endocrinology, focusing on Renin–angiotensin system in particular.
His Pregnancy research incorporates themes from Diabetes mellitus, Pravastatin, Pathophysiology and Disease.
His Blood pressure research is multidisciplinary, relying on both Gut flora, Gastrointestinal Microbiome, Experimental autoimmune encephalomyelitis, Encephalomyelitis and Autoimmunity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
